Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results Inv. presentation
|
Stoke Therapeutics, Inc. (STOK)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
03/17/2023 |
3
| Allan Jonathan (General Counsel & Corp Sec) has filed a Form 3 on Stoke Therapeutics, Inc. |
06/30/2021 |
3
| Skorpios Trust (10% Owner) has filed a Form 3 on Stoke Therapeutics, Inc. |
01/27/2021 |
3
| Menzel Garry E (Director) has filed a Form 3 on Stoke Therapeutics, Inc. |
06/05/2020 |
3
| Smith Julie (Director) has filed a Form 3 on Stoke Therapeutics, Inc. |
11/18/2019 |
3
| Walker Robin A. (Chief Legal Officer) has filed a Form 3 on Stoke Therapeutics, Inc. |
06/19/2019 |
3
| Burstein Jennifer (Director) has filed a Form 3 on Stoke Therapeutics, Inc. |
06/18/2019 |
3
| Tulipano Stephen J (CFO) has filed a Form 3 on Stoke Therapeutics, Inc. |
06/18/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
06/18/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
06/18/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
06/18/2019 |
3
| Kaye Edward M. MD (CEO) has filed a Form 3 on Stoke Therapeutics, Inc. |
06/18/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
06/18/2019 |
3
| LEVIN ARTHUR A (Director) has filed a Form 3 on Stoke Therapeutics, Inc. |
06/18/2019 |
3
| TZIANABOS ARTHUR (Director) has filed a Form 3 on Stoke Therapeutics, Inc. |
06/18/2019 |
3
| Redmile Group, LLC (10% Owner) has filed a Form 3 on Stoke Therapeutics, Inc. |
06/18/2019 |
3
| Harrison Seth Loring (10% Owner) has filed a Form 3 on Stoke Therapeutics, Inc. |
06/18/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
06/18/2019 |
3
| Apple Tree Partners IV, L.P. (10% Owner) has filed a Form 3 on Stoke Therapeutics, Inc. |
06/18/2019 |
3
| RTW INVESTMENTS, LP (10% Owner) has filed a Form 3 on Stoke Therapeutics, Inc. |
|
|